Keywords
Child
Adolescent
Blood Glucose Self-monitoring
Flash Glucose Monitoring System
How to Cite
Abstract
Introduction: Type 1 diabetes mellitus (DM1) is one of the most frequent endocrine pathologies in pediatric population. Capillary blood glucose testing, the most recommended self-monitoring method, is associated with discomforts that could decrease adherence. This led to creation of new technologies that respond to patients’ needs.
Objective: To generate recommendations based on experts consensus about the use of the flash glucose monitor (FGM) in patients under 18 years of age with DM1 diagnosis.
Materials and methods: A modified Delphi-type consensus was carried out in which 8 specialists in pediatric endocrinology and a developer group participated. Based on the analysis of the results, the recommendations were presented.
Results: Recommendations about indications, frequency and mode of use, safety profile and impact of its use on quality of life were obtained.
Conclusions: The FGM has a precision comparable with capillary glucose. It is considered a safe device, with the ability to impact positively the quality of life of the patients and their caregivers.
References
Patterson CC, Karuranga S, Salpea P, Saeedi P, Dahlquist G, Soltesz G, et al. Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9.a edición. Diabetes Res Clin Pract. 2019;157:107842.
Atlas de la Diabetes de la FID. 9.a edición. Federación Internacional de Diabetes; 2019.
Aschner P. Epidemiología de la diabetes en Colombia. Av Diabetol. 2010;26(2):95-100.
Boucher SE, Gray AR, de Bock M, Wiltshire EJ, Galland BC, Tomlinson PA, et al. Effect of 6 months’ flash glucose monitoring in adolescents and young adults with type 1 diabetes and suboptimal glycaemic control: managing diabetes in a ‘flash’ randomised controlled trial protocol. BMC Endocr Disord. 2019;19(1):50.
Al Hayek AA, Robert AA, Al Dawish MA. Evaluation of FreeStyle Libre Flash Glucose Monitoring System on Glycemic Control, Health-Related Quality of Life, and Fear of Hypoglycemia in Patients with Type 1 Diabetes. Clin Med Insights Endocrinol Diabetes. 2017;10:1179551417746957.
Edge J, Acerini C, Campbell F, Hamilton-Shield J, Moudiotis C, Rahman S, et al. An alternative sensor-based method for glucose monitoring in children and young people with diabetes. Arch Dis Child. 2017;102(6):543-549.
Boulkedid R, Abdoul H, Loustau M, Sibony O, Alberti C. Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review. PLoS One. 2011;6(6):e20476.
Manterola DC, Zavando MD. Cómo interpretar los “Niveles de Evidencia” en los diferentes escenarios clínicos. Rev Chil Cir. 2009;61(6):582-95.
Matas A, Matas A. Diseño del formato de escalas tipo Likert: un estado de la cuestión. Rev Electrónica Investig Educ. 2018;20(1):38-47.
Hansen EA, Klee P, Dirlewanger M, Bouthors T, Elowe-Gruau E, Stoppa-Vaucher S, et al. Accuracy, satisfaction, and usability of a flash glucose monitoring system among children and adolescents with type 1 diabetes attending a summer camp. Pediatr Diabetes. 2018;19(7):1276-84.
Pintus D, Ng SM. Freestyle libre flash glucose monitoring improves patient quality of life measures in children with Type 1 diabetes mellitus (T1DM) with appropriate provision of education and support by healthcare professionals. Diabetes Metab Syndr. 2019;13(5):2923-6.
Landau Z, Abiri S, Gruber N, Levy-Shraga Y, Brener A, Lebenthal Y, et al. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience. Acta Diabetol. 2018;55(12):1303-10.
Moser O, Yardley JE, Bracken RM. Interstitial Glucose and Physical Exercise in Type 1 Diabetes: Integrative Physiology, Technology, and the Gap In-Between. Nutrients. 2018;10(1):93.
Deeb A, Yousef H, Al Qahtani N, Artan I, Suliman S, Tomy M, et al. Novel ambulatory glucose-sensing technology improves hypoglycemia detection and patient monitoring adherence in children and adolescents with type 1 diabetes. J Diabetes Metab Disord. 2019;18(1):1-6.
Massa GG, Gys I, Bevilacqua E, Wijnands A, Zeevaert R. Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion. Diabetes Res Clin Pract. 2019;152:111-8.
Campbell FM, Murphy NP, Stewart C, Biester T, Kordonouri O. Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study. Pediatr Diabetes. 2018;19(7):1294-301.
Dunn TC, Xu Y, Hayter G, Ajjan RA. Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: A European analysis of over 60 million glucose tests. Diabetes Res Clin Pract. 2018;137:37-46.
Pleus S, Kamecke U, Link M, Haug C, Freckmann G. Flash Glucose Monitoring: Differences Between Intermittently Scanned and Continuously Stored Data. J Diabetes Sci Technol. 2018;12(2):397-400.
Leelarathna L, Wilmot EG. Flash forward: a review of flash glucose monitoring. Diabet Med J Br Diabet Assoc. 2018;35(4):472-82.
Vergier J, Samper M, Dalla-Vale F, Ventura V, Baucher F, Joubert F, et al. Evaluation of flash glucose monitoring after long-term use: A pediatric survey. Prim Care Diabetes. 2019;13(1):63-70.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.